OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ACRV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACRV is expected to report earnings to rise 113.73% to -109 cents per share on August 11

Acrivon Therapeutics ACRV Stock Earnings Reports

Q2'25

Est.

$-1.09

Q1'25

Beat

by $0.50

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.15

Q2'24

Beat

by $0.23

The last earnings report on May 15 showed earnings per share of -50 cents, beating the estimate of -100 cents. With 83.26K shares outstanding, the current market capitalization sits at 38.88M.

View a ticker or compare two or three

Compare

ACRV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACRV
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACRV showed earnings on May 15, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

480 Arsenal Way

Phone

+1 617 207-8979

Employees

Web

https://www.acrivon.com